| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/03/2008 | CA2672196A1 Antagonists of the trpv1 receptor and uses thereof |
| 07/03/2008 | CA2672172A1 Bicyclic heterocyclic compounds as fgfr inhibitors |
| 07/03/2008 | CA2672155A1 Use of xanthohumol or isoxanthohumol as an active substance for the prevention and/or control of liver diseases |
| 07/03/2008 | CA2672088A1 Glucokinase activator |
| 07/03/2008 | CA2671900A1 Macromolecular conjugates of cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof |
| 07/03/2008 | CA2671766A1 Modulators of c3a receptor and methods of use thereof |
| 07/03/2008 | CA2670763A1 4-(1-amino-ethyl)-cyclohexylamine derivatives |
| 07/03/2008 | CA2670715A1 Nanoemulsion comprising aqueous components |
| 07/03/2008 | CA2670651A1 Reduction of cardiovascular symptoms |
| 07/03/2008 | CA2670645A1 Pyrimidine kinase inhibitors |
| 07/03/2008 | CA2669916A1 Use of serum amyloid a gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents |
| 07/03/2008 | CA2668159A1 Tricyclic heteroaryl compounds useful as inhibitors of janus kinase |
| 07/03/2008 | CA2664118A1 Protease inhibitors |
| 07/03/2008 | CA2662677A1 Kinase inhibitors for preventing or treating pathogen infection and method of use thereof |
| 07/03/2008 | CA2651942A1 1,2,3,4-tetrahydro-quinoline derivatives as cetp inhibitors |
| 07/02/2008 | WO2007087518A2 2-substituted benzimidazoles as selective androgen receptor modulators (sarms) |
| 07/02/2008 | EP1939295A1 Vaccine compostions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
| 07/02/2008 | EP1939291A2 Inhibitor oligonucleotides and their use for specific repression of a gene |
| 07/02/2008 | EP1939290A2 Gene expression control |
| 07/02/2008 | EP1939205A1 Tricyclic compound |
| 07/02/2008 | EP1939204A1 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 07/02/2008 | EP1939203A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta isoform |
| 07/02/2008 | EP1939202A1 Novel adenine compound |
| 07/02/2008 | EP1939201A1 Novel adenine compound |
| 07/02/2008 | EP1939200A1 Novel adenine compound |
| 07/02/2008 | EP1939199A1 Novel adenine compound |
| 07/02/2008 | EP1939198A1 Novel adenine compound |
| 07/02/2008 | EP1939197A1 8-ethinylxanthine derivatives as selective A2A receptor antagonists |
| 07/02/2008 | EP1939195A1 New indole derivatives and their use as medicine |
| 07/02/2008 | EP1939194A1 Bicyclic aromatic substituted pyridone derivative |
| 07/02/2008 | EP1939192A1 Cyclopentanone derivatives, method of synthesis and uses thereof |
| 07/02/2008 | EP1939191A1 Furan derivatives, method of synthesis and uses thereof |
| 07/02/2008 | EP1939189A1 Derivative having ppar agonistic activity |
| 07/02/2008 | EP1939188A1 Oxa-and thiazole derivatives useful as antidiabetic and antiobesity agents |
| 07/02/2008 | EP1939187A1 Substituted heteroaryl pyridopyrimidone derivatives |
| 07/02/2008 | EP1939186A1 5-Fluorouracil derivatives and their use for the treatment of cancer |
| 07/02/2008 | EP1939185A1 New types of hetaryl-phenylendiamin-pyrimidines as protein kinase inhibitors for the treatment of cancer |
| 07/02/2008 | EP1939183A1 Novel nitrogenated heterocyclic compound |
| 07/02/2008 | EP1939181A1 Heteroaryl-substituted carboxamides and use thereof for the stimulation of the expression of NO synthase |
| 07/02/2008 | EP1939180A1 Heteroarylacrylamides and their use as pharmaceuticals for the stimulation of the expression of endothelial NO synthase |
| 07/02/2008 | EP1939179A1 Stable S-nitrosothiols, method of synthesis and use |
| 07/02/2008 | EP1939176A1 Salts of Tegaserod |
| 07/02/2008 | EP1939175A1 Sulfonamide derivative having pgd2 receptor antagonistic activity |
| 07/02/2008 | EP1939174A1 Inclusion complex of ezetimibe and a cyclodextrin and processes in the preparation thereof |
| 07/02/2008 | EP1939173A1 O-substituted-dibenzyl urea- or thiourea- derivatives as trpv1 receptor antagonists |
| 07/02/2008 | EP1939166A1 Plants extracts for use in brain modulation |
| 07/02/2008 | EP1938841A2 Synergistic composition for modulating activity of substrate analogs for NAD+, NADP+, NADH+ or NADPH dependent enzymes and process thereof |
| 07/02/2008 | EP1938840A1 Duloxetine composition |
| 07/02/2008 | EP1938839A1 Ophthalmic compositions of parasympathetic stimulants and anti-inflammatories for use in the treatment of presbyopia |
| 07/02/2008 | EP1938838A1 Histamine h3 agonist for use as therapeutic agent for lipid/glucose metabolic disorder |
| 07/02/2008 | EP1938837A1 Preventive or therapeutic agent for disease caused by decrease in lacrimal fluid |
| 07/02/2008 | EP1938828A1 Use of lupulones for the prevention and treatment of colorectal cancer |
| 07/02/2008 | EP1938824A1 Medicine, food and drink or feed containing sphingomyelin |
| 07/02/2008 | EP1938823A1 Agent for preventing or treating pancreas cancer, ovary cancer or liver cancer containing novel water-soluble prodrug |
| 07/02/2008 | EP1938822A1 Combination therapy for the treatment of airways disease |
| 07/02/2008 | EP1938821A2 Methods of administering epothilone analogs for the treatment of cancer |
| 07/02/2008 | EP1938820A1 Liquid preparation for external application containing indomethacin |
| 07/02/2008 | EP1938819A2 Use of specific cyclolignans |
| 07/02/2008 | EP1938818A2 Use of specific cyclolignans |
| 07/02/2008 | EP1938817A2 Pharmaceutical compositions comprising metals for modulating epithelial cell-to-cell adhesion |
| 07/02/2008 | EP1938816A2 Compounds and methods for inducing apoptosis in cancer cells |
| 07/02/2008 | EP1938815A1 Pharmaceutical for prevention and treatment of ophthalmic disease induced by increase in vasopermeability |
| 07/02/2008 | EP1938814A1 Pharmaceutical for protection of motor nerve in patient with amyotrophic lateral sclerosis |
| 07/02/2008 | EP1938813A1 Agent for reduction of oxidized albumin level |
| 07/02/2008 | EP1938812A1 Pharmaceutical composition using aliskiren and avosentan |
| 07/02/2008 | EP1938811A1 Medicinal composition for treating bulimia and depression accompanying bulimia |
| 07/02/2008 | EP1938810A1 Ameliorating agent for metabolic syndrome |
| 07/02/2008 | EP1938809A1 Adhesive skin patch |
| 07/02/2008 | EP1938808A1 Preparation for external use |
| 07/02/2008 | EP1938805A1 Monolithic sustained release zolpidem tablets |
| 07/02/2008 | EP1938804A1 Pharmaceutical formulation comprising neurokinin antagonist |
| 07/02/2008 | EP1938803A2 Formulations comprising nanoparticulate meloxican |
| 07/02/2008 | EP1938801A1 Nanoemulsion |
| 07/02/2008 | EP1938800A1 Sirolimus nanodispersion |
| 07/02/2008 | EP1938799A1 Methods and compositions for treating and preventing posterior segment ophthalmic disorders |
| 07/02/2008 | EP1938798A1 Pharmaceutical formulations of antineoplastic agents, in particular temozolomide, processes of making and using the same |
| 07/02/2008 | EP1938699A1 Extract liquid containing -cryptoxanthin ingredient, and food or beverage and soap or cosmetic each containing the extract liquid |
| 07/02/2008 | EP1937825A2 Modified 4'-nucleosides as antiviral agents |
| 07/02/2008 | EP1937815A1 Methods and compositions for modulating tumor cell activity |
| 07/02/2008 | EP1937813A2 Modulation of glucagon receptor expression |
| 07/02/2008 | EP1937812A2 Methods and compositions for treating immune disorders |
| 07/02/2008 | EP1937802A1 THE USE OF siRNAs IN ORGAN STORAGE/REPERFUSION SOLUTIONS |
| 07/02/2008 | EP1937699A2 Hypophosphorous acid derivatives and their therapeutical applications |
| 07/02/2008 | EP1937690A1 Thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors |
| 07/02/2008 | EP1937688A1 Imidazo benzodiazepine derivatives |
| 07/02/2008 | EP1937687A1 7-[2-[4-(6-FLUORO-3-METHYL-1,2-BENZISOXAZOL-5-YL)-1-PIPERAZINYL]ETHYL]2-(1-PROPYNYL)-7H-PYRAZOLO-[4,3-e]-[1,2,4]-TRIAZOLO-[1,5-c]-PYRIMIDIN-5 AMINE |
| 07/02/2008 | EP1937686A1 New anti-malaria derivatives of 4-aminoquinoline |
| 07/02/2008 | EP1937685A1 Tetrahydro-pyrrolizinone compounds as lfa-i mediators |
| 07/02/2008 | EP1937682A1 Met kinase inhibitors |
| 07/02/2008 | EP1937681A1 5-oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of c-fms kinase |
| 07/02/2008 | EP1937680A2 Novel imidazo [4,5 -b] pyridine derivatives as inhibitors of glycogen synthase kinase 3 for use in the treatment of dementia and neurodegenerative disorders |
| 07/02/2008 | EP1937679A2 Preparation and use of tetrahydropyrrolo [3, 2-c] pyridin-4-one derivatives for treatment of obesity, psychiatric and neurological disorders |
| 07/02/2008 | EP1937678A1 Hiv integrase inhibitors |
| 07/02/2008 | EP1937677A1 Cb-1 modulating compounds and their use |
| 07/02/2008 | EP1937676A1 Biocompatible fluorescent imaging agents |
| 07/02/2008 | EP1937674A1 Isoxazole derivatives |
| 07/02/2008 | EP1937673A1 Imidazole derivatives as inhibitors of tafia |
| 07/02/2008 | EP1937672A1 N-[(4,5-diphenylpyrimidin-2-yl)methyl]amine derivatives, the preparation thereof and their therapeutic use |
| 07/02/2008 | EP1937671A2 Benzimidazole thiophene compounds as plk inhibitors |
| 07/02/2008 | EP1937670A1 Benzimidazolones which have activity at m1 receptor |